CLINICAL_TRIALS trial_result · 2019-12-10

Clinical Trial Update: Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 [Phase 3]

Phase 3 extension study evaluating post-treatment safety and duration of clinical effect for LIPO-202 was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Evofem Inc. | Conditions: Central Abdominal Bulging | Phase 3 | Status: TERMINATED | Results posted: 2019-12-10